Nordicus Partners Corporation Common Stock (OTC:NORD)
| Market Cap | 98.97M+1.8% |
| Revenue (ttm) | 0-100.0% |
| Net Income | -5.07M-31.7% |
| EPS | -0.27+28.2% |
| Shares Out | 19.44M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | Mar 10, 2022 |
| Volume | 29,208 |
| Open | 4.00 |
| Previous Close | 4.01 |
| Day's Range | 4.00 - 5.15 |
| 52-Week Range | 1.48 - 5.15 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
About NORD
Nordicus Partners Corporation functions as a publicly traded entity that acts as both a business accelerator and a holding company, specifically supporting Nordic life sciences firms operating within the United States. A central focus for the company involves advancing oral healthcare through the development of new medicines. In addition to its core operations, Nordicus offers an array of corporate finance and advisory services. These include aiding in business and market expansion, formulating strategic growth plans, identifying and acquiring talent, fostering key partnerships, facilitating capital raising efforts, and orchestrating company acquisitions or sales. The organization, which was established in 1993 and is headquartered in Beverly Hills, California, rebranded as Nordicus Partners Corporation in May 2023, having previously been known as EKIMAS Corporation.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Ask Barron about NORD
$NORD stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in NORD holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by NORD's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
NORD Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New NORD patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to NORD from public contracts
Source: USAspending.gov
NORD Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from NORD’s recent data — informational, not investment advice